NASDAQ:MBX | Income Statement | MBX Biosciences, Inc.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$30.99M$40.93M-$40.93M-$37.1M-$0.78-$0.7847,696,36347,696,363
2026-03-31$18.47M$27.27M-$27.27M-$23.52M-$0.50-$0.5046,576,20446,576,204
2025-12-31$19.76M$25.8M-$25.8M-$22.06M-$0.45-$0.452,817,4232,817,423
2025-09-30$19.27M$23.93M-$23.93M-$21.62M-$0.63-$0.6334,198,59734,198,597
2025-06-30$17.72M$21.81M-$21.81M-$19.41M-$0.58-$0.5833,446,38533,446,385
2025-03-31$22.41M$26.53M-$26.53M-$23.88M-$0.71-$0.7133,412,38633,412,386
2024-12-31$15.22M$18.61M-$18.61M-$15.59M$9.60$9.607,638,5727,638,572
2024-09-30$16.75M$19.61M-$19.61M-$18.14M-$2.78-$2.786,515,6166,515,616
2024-06-30$14.4M$16.66M-$16.66M-$15.86M-$12.62-$12.621,256,5491,256,549
2024-03-31$11.05M$13.31M-$13.31M-$12.34M-$10.26-$10.261,202,3961,202,396
2023-12-31$7.73M$9.99M-$9.99M-$8.84M-$7.68-$7.6841,93341,933
2023-09-30$9.07M$10.95M-$10.95M-$10.16M-$9.40-$9.401,081,3491,081,349
2023-06-30-$7.61M
2023-03-31-$5.95M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$79.16M$98.06M-$98.06M-$87M$0.00-$86.97M-$2.38-$2.3836,506,09236,506,092
2024-12-31$57.42M$68.19M-$68.19M-$61.9M$0.00-$61.92M-$5.82-$5.8210,642,95410,642,954
2023-12-31$28.53M$35.31M-$35.31M$0.00-$32.56M-$31.96-$31.961,018,7571,018,757